Background: Several studies discussed the relations between asthma and rheumatoid arthritis (RA) but the results were controversial. These studies were either questionnaire based or with small study populations. We aimed to examine the risk of asthma among RA patients in a nationwide population. Methods: We conducted a cohort study using data from the National Health Insurance system of Taiwan. The RA cohort included 27 602 patients who were newly diagnosed and recruited between 1998 and 2008. Each patient was randomly frequency-matched with three people without RA on age group, sex and the year of index date from the general population. The occurrence of asthma was followed up until the end of 2010. The relative risks of asthma were estimated using Cox proportional hazard models after adjusting for age and comorbidities.
Introduction
Rheumatoid arthritis (RA) is a disease involving inflammatory reaction of the immune system against body tissues, leading to joint destruction and physical disability. RA imposes substantial social costs, including an increased risk of work-related disability and accelerated mortality. 1 It has been estimated that $50% of RA patients will develop some form of respiratory abnormality during their lifetime. 2 In fact, one study by Toyoshima et al. placed pulmonary disease as the second leading cause of death in RA patients accounting for $20% of their mortality. 3 Although rheumatoid arthritis-associated interstitial lung disease (RA-ILD) remains the most debilitating and famous complication, airway disorders may also play an important role of respiratory abnormality. 4 RA is a chronic immune disorder of unknown cause. The inflamed synovium is infiltrated with CD4+ T cell, most of them expressing several activation markers. 5 Th1 cells produce interleukin 2 (IL-2) and interferon g (IFN g) and are involved in delayed-type hypersensitivity and macrophage activation. Th2 cells produce IL-4, IL-5, IL-10 and IL-13 and are involved in allergy and those responses to parasites. Each subset, Th1 and Th2, regulates the other in a dynamic process. 6 RA is generally thought to be a Th1 disease as T-cell clones from synovium or peripheral blood usually having a Th1-like phenotype. 7 Atopy is clearly a Th2 disease and is a genetically determined disorder in which the immunoglobulin E (IgE) antibody is formed in response to specific allergens. 8 Asthma is a chronic inflammatory disorder of the airways and it is one of the representative diseases of atopic disorders. There have been several reports that atopic diseases are less common in patients with RA than in normal controls. 6, [9] [10] [11] [12] [13] [14] In contrast, Kero et al. 15 have reported that the cumulative incidence of asthma in children with RA was significantly higher than children without RA. However, these studies were either only questionnaire based or with small study populations.
This study attempts to determine if there is a differential risk of asthma for adults with and without RA by examining a relative big cohort in Taiwan. The results in this study were generated from a population-based retrospective cohort obtained from the National Health Insurance (NHI) system's database. To the best of our knowledge, this is the first nationwide population-based study evaluating the relationship between RA and asthma risk.
Materials and methods

Data source
A compulsory NHI program was implemented in Taiwan since 1995 and it covers $99% of all residents of Taiwan, which includes 23.74 million beneficiaries. 16 The NHI program includes coverage for outpatient visits, hospital admissions, emergency and prescriptions. The data used in the present study were extracted from the National Health Research Institute Database (NHIRD) released by the Taiwan National Health Research Institute. This dataset contained deidentified secondary data; therefore no information could be used to identify any individual. Our study was exempted from full review by the institutional Research Ethic Committee (CMU-REC-101-012). The diagnoses and procedures coded in the International Classification of Disease, Ninth Revision, Clinical Modification (ICD-9-CM) format.
Study population
All RA (ICD-9-CM 714) patients were identified from the Registry of Catastrophic Illness Database (RCIPD) of NHIRD from 1998 to 2008 and the first-time RA diagnosis date was served as the index date. In Taiwan patients need clinical physician to confirm their illness for applying for a qualified catastrophic illness certificate.) Finally, we extracted 27 602 RA patients with complete age or sex information and without a history of asthma (ICD-9-CM 493-494) before the index date to be the RA cohort. Three non-RA control subjects for each RA case were frequency-matched with the RA cohort on age group with an interval of 5-year, gender and the year of index date. Selected control individuals with a history of asthma (ICD-9-CM 493-494) before the index date, with incomplete age or sex information were excluded and replaced with another qualified control subjects. A total of 27 602 RA patients and 82 806 non-RA control subjects were followed up until a diagnosis of asthma, loss to follow-up, death, withdrawal from insurance and the end of 2010, whichever date came first.
Comorbidities
The baseline comorbidity history for each participant was determined from the inpatient claims data. We selected several well-known risk factors of asthma including rhinitis (ICD-9-CM 472-477), chronic sinusitis (ICD-9-CM 473), gastro-esophageal reflux disease (GERD) (ICD-9-CM 530.11, 530.81) and obstructive sleep apnea (OSA) (ICD-9-CM 780) and another obstructive airway disease, chronic obstructive pulmonary disease (COPD) (ICD-9-CM 490-492, 494, 496), to be the comorbidities. These chosen comorbidities can help to clarify the independent influence of RA on asthma risk.
Statistical analysis
All data processing and statistical analyses were performed with the SAS software version 9.2 (SAS Institute, Inc., Cary, NC, USA). A two-tailed P-value of <0.05 was considered statistically significant. We described and compared the distributions of age, sex and comorbidities (%) between the cohorts with and without RA by Chi-square tests. The asthma free Kaplan-Meier curves of the two cohorts were compared with the log-rank test. The incidence density rates (per 1000 person-years) were estimated for both the cohorts by associated demographic variables and comorbidities. The relative incidence rate ratio (IRR) of developing asthma in patients with RA, compared with those without RA, was analyzed using Poisson regression. The multivariable Cox's proportion hazard regression was used to examine the effect of RA on the risk of asthma, shown as a hazard ratio (HR) with a 95% confidence interval (CI). We further analyzed the interaction between the RA status and any comorbidity. Further analysis was performed to assess whether the association of asthma varied according to the length of the follow-up period after RA was diagnosed which also help to validate the proportional hazard assumption of Cox model. Deviance residual plot was used to detect possible poorly fitted and influential observations. Finally, the adequacy of Cox Proportional Hazard Model was assessed with Grønnesby and Borgan test.
Results
The distributions of the demographic variables and comorbidities for the RA and non-RA cohorts are shown in Table 1 . Males were outnumbered by females (22.2% vs. 77.8%). The mean (AE standard deviation) age of non-RA cohort was 53.2(AE14.2) years and RA cohort was 53.6(AE13.9) years, with 50.2% of them aged 40-60 years old. The RA cohort was more prevalent with comorbidities than the non-RA cohort (all P < 0.0001).
In total, 824 asthma patients were observed among the RA cohort with an incidence rate of 4.56 per 1000 person-years and 1229 among the non-RA cohort with an incidence rate of 2.22 per 1000 person-years, yielding a IRR of 2.07 (95% CI = 1.99-2.15) and adjusted HR of 2.07 (95% CI = 1.89-2.26) ( Table 2 ). The sex-specific incidence rate for female and male were 4.59 and 4.42 per 1000 person-years in RA cohort, respectively. Female with RA had a higher risk of asthma than the female comparison cohort (adjusted HR = 2.18, 95% CI = 1.97-2.41). An age-specific analysis showed that RA patients had a higher incidence rate of asthma development than the non-RA cohort in all age groups, and that the asthma incidence rate increased with age. Patients aged <40 years old with RA had a 3.26-fold higher risk of asthma than the comparison cohort (adjusted HR = 3.26, 95% CI = 2.09-5.11). The incidence rate of asthma increased with any comorbidity in both cohorts. The Kaplan-Meier survival analysis showed that the asthma-free rate was 2.3% less in the RA cohort than non-RA cohort (Figure 1 , P-value < 0.001). The results of univariable and multivariable Cox proportional hazard analyses for asthma-association risk factor in patients with RA are shown in Table 3 . Older age (HR = 9.09 for 560 years, 95% CI = 7.23-11.4), comorbidity of COPD (HR = 4.61, 95% CI = 3.93-5.40), rhinitis (HR = 2.08, 95% CI = 1.36-3.17) and OSA (HR = 1.57, 95% CI = 1.30-1.90) were associated with increased risk of asthma.
Furthermore, relative to the non-RA cohort without any comorbidity, the RA patients with any comorbidity were at a much higher risk of asthma (HR = 4.73, 95% CI = 3.99-5.60) compared with patients with comorbidities alone (HR = 2.95, 95% CI = 2.53-3.45) or with RA alone (HR = 2.16, 95% CI = 1.96-2.38) ( Table 4 , the P-value of interaction <0.001). Compared without RA and aged 20-39 years old, patients with RA and aged 560 years old were 21.2-fold more likely to develop asthma (95% CI, 15.1-29.8), followed by patients without RA and aged 560 years old (HR = 11.9, 95% CI = 8.50-16.6) for developing asthma. In order to evaluate the assumption of proportional hazards for Cox regression, Table 5 presents the comparisons of the risks of asthma by stratifying the follow-up durations. The adjusted HR of asthma slightly decreased with the increased follow-up durations, the RA cohort followed-up for <3 years was associated with the highest risk of asthma (adjusted HR = 2.15, 95% CI = 1.88-2.45), followed by those with 4-6 years of follow-up (adjusted HR = 2.07, 95% CI = 1.77-2.43), 7-9 years (adjusted HR = 2.03, 95% CI = 1.63-2.52) and >9 years (adjusted HR = 1.74, 95% CI = 1.22-2.46). The relative hazards were $2-fold across the four different follow-up durations, so the assumption of proportional hazards for Cox regression was valid. Deviance residual plot showed a small portion (0.34%) of potential outliers with an absolute deviance residual >3. Finally, the Grønnesby and Borgan test supported the adequacy of Cox proportional hazard model for the data (P = 0.1312).
Discussion
To the best of our knowledge, this is the first nationwide population-based study evaluating the relationship between RA and asthma risk. In this study, there was a significantly higher incidence of asthma among RA patients than that in the general population. Further analyses indicated that the presence of an enhanced correlation between the female sex of RA and asthma. Furthermore, the HR of asthma was higher in younger subjects although the asthma incidence rate increased with age. The possible explanation might be that old patients apt to have more comorbid diseases in each RA and non-RA cohorts, which might be risk factors of late onset asthma. Therefore, the HR of old age groups was lower than young age group.
Several studies have shown decreased risk of atopic diseases in RA patients. Most of them suppose that patients with autoimmune disease are Patients with any one of the comorbidities (rhinitis, chronic sinusitis, GERD, COPD, and OSA) were classified as the comorbidity group; * P < 0.001 'protected' from developing atopic disorders or the establishment of an atopic phenotype reduces the risk of the subsequent development of autoimmune diseases. Some of them discussed the relations between asthma and RA, but the results were controversial. Rudwaleit et al. 10 reported that 21/487 (4.3%) patients with RA but 35/536 (6.5%) controls had asthma. Kaptanoglu et al. 12 observed the prevalence rates of asthma were 3.2% and 6.5%, respectively, in the RA group and the control group. Hajdarbegovic et al.
14 reported the percentage of patients diagnosed with asthma was lower in the RA group than that in the control group (8% vs. 14%). However, the difference of above studies all did not reach statistical significance. In contrast, Kero et al. 15 concluded that the cumulative incidence of asthma in children with RA was significantly higher than children without RA. Nevertheless, the primary limitations of above studies were either only questionnaire based or with small study populations. In this study, we could find an increased incidence rate of asthma in RA patients in all age and sex subgroups.
Asthma is a chronic inflammatory disorder of the airways and there are a number of factors that influence a person's risk of developing asthma. The search for genes linked to the development of asthma has focused on four major areas: production In 2006, the National Health Interview Survey estimated that 16.1 million adults (7.3% of the population) and 6.8 million children (9.4% of the population) in the USA had a diagnosis of asthma. The prevalence of asthma decreases with increasing age. There are important racial differences in the prevalence and morbidity. Females had a 40% higher prevalence rate than males; however, boys under the age of 18 years had a higher prevalence than girls.
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RA is also a chronic inflammatory disease characterized by joint swelling, joint tenderness and destruction of synovial joints, leading to severe disability and premature mortality. 19 Given the presence of autoantibodies, such as rheumatoid factor (RF) and anti-citrullinated protein antibody (ACPA), which can precede the clinical manifestation of RA by many years, RA is considered an autoimmune disease. 20 Autoimmunity and the overall systemic and articular inflammatory load drive the destructive progression of the disease. 21 The annual incidence of RA was 15.8 cases per 100 000 population in a recent Taiwan study. Consistent with estimates from Europe and the USA, we found a high incidence of RA in women; the incidence was 4-fold higher than that in men. 22 The balance between Th1 and Th2 cells is critical in inflammatory and immune disorders. RA is classified as a Th1 immune disease, with less IL-4 than IFN-g in the inflamed joints. 23 Atopy involves the activation of Th2 cells, due to interaction with antigen-presenting B cells. 24 Some investigators hypothesized that a Th1 response protects against or limits the development of Th2 atopic conditions. In this study, we did not overthrow this argument.
Although asthma is one of the representative diseases of atopic disorders, the pathophysiological mechanisms were very complex. Factors that cause the development of asthma include host factors such as genetic factors, obesity, sex and environmental factors such as allergens, infections, occupational exposure, tobacco smoke, air pollution or diet. Additionally, racial and ethnic differences, lifestyle, socioeconomic status and integrity of public health system have been linked to prevalence of asthma. Besides, the developments of asthma in adults are less well defined than those in childhood. Non-atopic asthma and overlapping syndrome with chronic obstructive pulmonary disease (COPD) may play much important roles in adult patients. In summary, increased incidence of asthma in RA patients did not reflect the complete relations between atopy and RA.
The strengths of our study included its use of population-based data that are highly representative of the general population. However, certain limitations to our findings should be considered. First, the National Health Insurance Research Database (NHIRD) does not contain detailed information regarding smoking habits, diet preference, occupational exposure, reproductive history, drug history and family history of systemic diseases, all of which may be risk factors for RA. Second, the evidence derived from a retrospective cohort study is generally lower in statistical quality than that from randomized trials because of potential biases related to adjustments for confounding variables. Despite our meticulous study design and control for confounding factors, bias resulting from unknown confounders may have affected our results. Third, all data in the NHIRD are anonymous. Thus, relevant clinical variables, such as serum laboratory data, pulmonary function tests, imaging results and pathology findings were unavailable for the patients in our study. Last but not least, the register of NHIRD was established since 1995, so unrecorded occurrences of asthma could have occurred before 1995. We expect most rheumatologists evaluate a patient's medical history including asthma in a comprehensive way when they are verifying the diagnosis of RA. Therefore, if the patient was diagnosed with asthma after RA, then it is supposed to be a new one instead of a pre-existing problem. Otherwise, the data regarding RA and asthma diagnoses were nonetheless reliable.
Conclusion
To the best of our knowledge, this is the first nationwide population-based study evaluating the relationship between RA and asthma risk. Patients with RA had a significantly higher risk of developing asthma than healthy people in all sex and age subgroups. Further analyses indicated that there was a higher risk for asthma in women with RA than in men with RA when compared with their counterpart. Similarly, the HR of asthma associated with RA was higher in younger subjects, although the incidence rate increased with age.
